Stereoselective inhibition of serotonin transporters by antimalarial compounds.
Stereoselective inhibition of serotonin transporters by antimalarial compounds.
复制标题
DOI:
10.1016/j.neuint.2013.10.009
复制
发表时间:
2014-07
影响因子:
4.2
通讯作者:
Henry LK
中科院分区:
文献类型:
--
作者:
Beckman ML;Pramod AB;Perley D;Henry LK
The serotonin (5-HT) transporter (SERT) is an integral membrane protein that functions to reuptake 5-HT released into the synapse following neurotransmission. This role serves an important regulatory mechanism in neuronal homeostasis. Previous studies have demonstrated that several clinically important antimalarial compounds inhibit serotonin (5-hydroxytryptamine, 5-HT) reuptake. In this study, we examined the details of antimalarial inhibition of 5-HT transport in both Drosophila (dSERT) and human SERT (hSERT) using electrophysiologic, biochemical and computational approaches. We found that the cinchona alkaloids quinidine and cinchonine, which have identical stereochemistry about carbons 8 and 9, exhibited the greatest inhibition of dSERT and hSERT transporter function whereas quinine and cinchonidine, enantiomers of quinidine and cinchonine, respectively, were weaker inhibitors of dSERT and hSERT. Furthermore, SERT mutations known to decrease the binding affinity of many antidepressants affected the cinchona alkaloids in a stereo-specific manner where the similar inhibitory profiles for quinine and cinchonidine (8S,9R) were distinct from quinidine and cinchonine (8R,9S). Small molecule docking studies with hSERT homology models predict that quinine and cinchonidine bind to the central 5-HT binding site (S1) whereas quinidine and cinchonine bind to the S2 site. Taken together, the data presented here support binding of cinchona alkaloids to two different sites on SERT defined by their stereochemistry which implies separate modes of transporter inhibition. Notably, the most potent antimalarial inhibitors of SERT appear to preferentially bind to the S2 site. Our findings provide important insight related to how this class of drugs can modulate the serotonergic system as well as identify compounds that may discriminate between the S1 and S2 binding sites and serve as lead compounds for novel SERT inhibitors.
登录
查看更多内容
影响因子:
64.8
作者:
BLAKELY, RD;BERSON, HE;BRADLEY, CC
通讯作者:
BRADLEY, CC
影响因子:
4.7
作者:
Beckman, ML;Quick, MW
通讯作者:
Quick, MW
DOI:
10.1074/jbc.m112.343681
发表时间:
2012-05-25
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Bulling S;Schicker K;Zhang YW;Steinkellner T;Stockner T;Gruber CW;Boehm S;Freissmuth M;Rudnick G;Sitte HH;Sandtner W
通讯作者:
Sandtner W
影响因子:
14.8
作者:
Combs SA;Deluca SL;Deluca SH;Lemmon GH;Nannemann DP;Nguyen ED;Willis JR;Sheehan JH;Meiler J
通讯作者:
Meiler J
DOI:
10.1152/ajpgi.1998.275.3.g433
发表时间:
1998-09-01
影响因子:
4.5
作者:
Chen, JX;Pan, H;Gershon, MD
通讯作者:
Gershon, MD